Biopassion DiagnosticsHome › Health Blog › Breast Cancer Awareness Month

Breast Cancer Awareness Month: The Complete Guide to Early Detection, Testing and Action

By Biopassion Diagnostics | Published 3 October 2026 | 14 minute read

Every October, the world turns pink. But after four decades of Breast Cancer Awareness Month, one question matters most: is awareness enough? This guide covers where the campaign came from, what the latest breast cancer numbers say, how screening and lab testing work, and how employers and clinics can turn awareness into action.

The story behind the statistics

Imagine Amina, a 38 year old school administrator in Nairobi. This is an illustrative story, not a real patient.

For two months, Amina notices a small, firm lump while dressing. She tells herself it is stress, hormones, a busy school term. “I’m fine,” she says. Then a colleague mentions a workplace screening day, and she books a clinical breast exam. The nurse refers her for an ultrasound. The radiologist recommends a biopsy. The sample goes to a laboratory, and within days a pathology report gives her a clear answer, so her doctor can plan treatment while the cancer is still small.

Amina is made up, and not every lump is cancer. But the path is real. Every step depends on the one before it: noticing, checking, imaging, tissue testing and treatment. When one step is missing, months or years can be lost. This guide follows that path.

Key takeaways

• Breast cancer is the most common cancer in women worldwide and in Kenya.
• Globally, about 2.3 million women were diagnosed and 670,000 died in 2022.
• Survival depends heavily on how early the disease is found and where a woman lives.
• Screening finds possible cancer. A biopsy examined in the laboratory confirms it.
• Awareness works best when it ends in a booked test or a completed referral.

Where Breast Cancer Awareness Month came from

The campaign began in October 1985 as a partnership between the American Cancer Society and the pharmaceutical division of Imperial Chemical Industries, now part of AstraZeneca. Its goal was to promote mammography as a key tool against the disease. It started as a week long event opened by former First Lady Betty Ford, a breast cancer survivor, and October was formally proclaimed a national awareness month in 1990.

The pink ribbon came later. Activist Charlotte Haley first handed out peach coloured ribbons to draw attention to weak research funding. In 1991 the Susan G. Komen Foundation gave out pink ribbons at a New York race, and in 1993 Evelyn Lauder made pink the symbol of the Breast Cancer Research Foundation. Pink became the global colour of the cause.

A timeline of the campaign

• 1985 The American Cancer Society and a pharmaceutical company launch the first awareness week, promoting mammography.
• 1990 October is proclaimed National Breast Cancer Awareness Month in the United States.
• 1991 Susan G. Komen hands out pink ribbons at a New York race.
• 1993 The Breast Cancer Research Foundation adopts the pink ribbon as its symbol.
• 2021 The World Health Organization launches the Global Breast Cancer Initiative.
• 2025 An IARC study projects a 38% rise in cases and a 68% rise in deaths by 2050.

Breast cancer facts and statistics

2.3 millionnew cases worldwide in 2022

670,000deaths worldwide in 2022

1 in 20women diagnosed in a lifetime

+38%more cases projected by 2050

Every minute, four women are diagnosed with breast cancer and one dies from it. By 2050, annual cases are projected to reach 3.2 million and deaths 1.1 million, with deaths rising by 68%.

The gap between rich and poor countries is stark. In high income countries, 83% of diagnosed women survive. In low income countries, more than half of women diagnosed die from the disease. Where you live shapes whether a diagnosis is survivable.

In 2021 the World Health Organization launched the Global Breast Cancer Initiative to cut breast cancer deaths by 2.5% each year, which would avert 2.5 million deaths between 2020 and 2040. It focuses on early detection, timely diagnosis and access to treatment. Only seven countries currently meet that yearly target.

Breast cancer in Kenya

Breast cancer is the most common cancer in Kenya. Recent reports citing the National Cancer Institute and the Ministry of Health put the toll at roughly 6,800 new cases and 3,100 deaths a year. About 68.5% of patients are diagnosed at Stage III or IV, when treatment is harder, costlier and less likely to succeed. A Ministry of Health survey also found that many women with abnormal ultrasound or mammography findings were never referred for a proper diagnosis.

The problem is rarely awareness alone. It is late detection, gaps in referral and limited access to timely diagnostic testing.

Reflecting on October: what worked and what did not

What the campaign got right

Awareness campaigns moved breast cancer from a whispered diagnosis to a public cause. Women learned to recognise symptoms, families began to talk, and screening became part of health planning.

What critics say

• Pinkwashing: some companies promoted pink products to lift sales without giving meaningfully to research or patient support.
• Awareness without action: advocacy groups have urged that money spent on awareness be redirected towards research and care.
• Oversimplified messages: presenting mammography as the answer to prevention is misleading. Screening finds cancer. It does not prevent it.

The lesson is not to abandon October. It is to make every pink ribbon lead to something measurable: a test booked, a referral completed, a diagnosis made on time.

Warning signs and risk factors

Most breast changes are not cancer, but every new change deserves a check. See a clinician if you notice:

• A new lump or thickened area in the breast or underarm
• A change in the size or shape of a breast
• Skin dimpling, redness or scaling
• Nipple discharge, or a nipple that turns inward
• Persistent breast pain that does not settle

Risk factors include age, family history, inherited gene changes such as BRCA1 and BRCA2, alcohol use, excess weight and low physical activity. Having none of them does not mean you are safe, so regular checks matter for everyone.

How to check your breasts

Doctors now stress breast awareness: knowing how your breasts normally look and feel, and reporting any change quickly. A simple routine helps.

1. Look. Stand in front of a mirror with your arms down, then raised. Check for changes in size, shape, skin or the nipple.
2. Feel. Lie down and use the pads of your fingers in small circles, covering the whole breast, up to the collarbone and under the arm.
3. Repeat regularly. Pick a time that suits you, such as a few days after your period ends, so changes stand out.
4. Report changes. Do not wait to see if it goes away. Book a clinical check.

Self checks do not replace clinical exams or imaging. They help you notice what is new.

How breast cancer testing and diagnosis work

Detection is a pathway, not a single test.

1. Clinical breast exam and imaging. A trained health worker examines the breast, and ultrasound or mammography looks for suspicious areas. Your doctor will advise what suits your age and risk.
2. Biopsy and histopathology. A small tissue sample is examined in the laboratory. This is how cancer is confirmed or ruled out.
3. Receptor testing (ER, PR and HER2). Lab tests on the tumour show what fuels its growth and guide treatment choices.
4. Genetic testing. For people with a strong family history, testing can help assess inherited risk.
5. Baseline blood tests. A Full Blood Count and liver and kidney function tests help doctors plan treatment safely.

A routine blood test cannot screen for or diagnose breast cancer. The laboratory’s role is to make sure no abnormal finding is left without a clear answer.

Breast cancer stages explained

Staging describes how far the cancer has spread. It is one of the main factors in planning treatment.

• Stage 0: abnormal cells stay inside the milk ducts and have not invaded nearby tissue.
• Stage I and II: the cancer is small and limited to the breast or nearby lymph nodes. This is usually called early stage.
• Stage III: the cancer is larger or has reached more lymph nodes or tissues near the breast.
• Stage IV: the cancer has spread to other organs such as the bones, liver or lungs.

The earlier the stage at diagnosis, the more treatment options usually exist. That is why the 68.5% of Kenyan patients diagnosed at Stage III or IV is such an important number.

Treatment options

Treatment is planned by a specialist team and depends on the stage, the type of tumour and the laboratory results. The main options are:

• Surgery: removing the tumour (lumpectomy) or the whole breast (mastectomy).
• Radiotherapy: targeted radiation to destroy remaining cancer cells.
• Chemotherapy: medicines that kill fast growing cells.
• Hormone therapy: used when the tumour is ER or PR positive.
• Targeted therapy: used when the tumour is HER2 positive.

This is where accurate pathology matters. Receptor results tell the team which treatments are likely to work, so errors or delays in the lab can affect care.

Lowering your risk

No one can prevent every breast cancer, but some habits may lower risk:

• Limit alcohol
• Keep a healthy weight
• Stay physically active
• Breastfeed where possible
• Discuss hormone medicines with your doctor
• Know your family history and share it with your clinician

Myths and facts

Myth: Only women with a family history get breast cancer.Fact: many women diagnosed have no close relative with the disease. Myth: A painless lump is harmless.Fact: early breast cancer often causes no pain, so every new lump deserves a check. Myth: Only older women are affected.Fact: risk rises with age, but younger women are diagnosed too. Myth: Bras and deodorants cause breast cancer.Fact: they have not been shown to cause it. Myth: Breast cancer is always a death sentence.Fact: found early and treated well, many women survive. In high income countries 83% do. Myth: Men cannot get breast cancer.Fact: it is rare, but men can be affected.

Support and life after diagnosis

A diagnosis affects the whole person, not only the body. Counselling, support groups, family and faith communities all help. Employers can make a real difference by allowing flexible time for appointments and treatment, and by protecting privacy. Many survivors return to work and full lives, and their stories are one of the strongest reasons to check early.

How employers and clinics can act this October

Employers and HR teams

• Add women’s health to workplace wellness days
• Give staff time and a private route to clinical breast exams and screening
• Share clear information on signs, risk and where to get tested

Clinics and hospitals

• Build a reliable referral pathway so abnormal findings always lead to a diagnosis
• Partner with an accredited laboratory for histopathology and specialised testing

Wellness providers and insurers

• Support early detection programmes, since earlier diagnosis improves outcomes and reduces the burden of late stage care

Partner with Biopassion Diagnostics

We are a KMLTTB accredited medical laboratory in Nairobi, supporting clinics, employers and families with accurate results, convenient sample collection and timely reporting.WhatsApp usCall +254 704 150 555

Your Health IS OUR PASSION.

Frequently asked questions

When is Breast Cancer Awareness Month?

Every October.

Does a breast lump always mean cancer?

No. Many lumps are benign, but only a clinical check and, where needed, imaging and tissue tests can confirm what a lump is.

Can a blood test detect breast cancer?

No. Screening relies on clinical examination and imaging, and diagnosis relies on a biopsy examined in the laboratory.

Can men get breast cancer?

Yes, though it is rare. Any unusual lump should be checked.

How often should I be screened?

It depends on your age, family history and risk. Speak to your doctor to agree a plan.

At what age should I start screening?

Guidelines differ by country, but many recommend regular mammography starting between ages 40 and 50, and earlier for higher risk. Clinical breast exams and breast awareness apply at any age.

Is a breast lump always painful?

No. Many cancers cause no pain, so painless lumps still need checking.

What is a biopsy, and does it hurt?

A biopsy takes a small tissue sample, usually under local anaesthetic, which is examined under a microscope. You may feel pressure or brief discomfort.

Glossary

ScreeningChecking people with no symptoms to find disease early. DiagnosisConfirming what a symptom or abnormal finding is. MammogramA low dose X ray of the breast. UltrasoundSound wave imaging, often used to look at lumps. BiopsyRemoval of a small tissue sample for testing. HistopathologyExamination of tissue under a microscope to confirm disease. ER and PRHormone receptors that can fuel tumour growth. HER2A protein that drives growth in some breast cancers. BRCA1 and BRCA2Genes linked to inherited breast cancer risk. MetastasisSpread of cancer to other parts of the body.

This article is for general education and does not replace advice from a qualified healthcare professional. Biopassion Diagnostics | Nairobi, Kenya | +254 704 150 555 | www.biopassiondiagnostics.com